Catch up on February’s industry headlines, including an MRSA breakthrough, a patent lawsuit, and the latest updates on the coronavirus outbreak and its impact on the biotechnology industry worldwide.
Browsing: Disease Area > Bacterial
The development of a paper-based, point-of-care diagnostic test may enable clinicians to rapidly detect bacterial infections and their antibiotic susceptibility with a simple colorimetric readout.
Using machine-learning, researchers have discovered a new antibiotic that is able to kill bacteria resistant to other antibiotics.
Dressings are long-established in the medical field for keeping wounds clean and preventing secondary infections. Here, Tim Sandle discusses technological advances with dressings for wound treatment and detection, including the incorporation of antimicrobials
This opinion piece looks at the impact a precision (or personalized) medicine approach could have in sepsis, including early and accurate microbiologic diagnosis, determining the host immune response signature and assessing individual response to treatment.
Optimizing vaccine models for Streptococcus pneumoniae suggests that vaccine programs need to be tailored to target specific subgroups including age and geographical region.
Take a look at the industry headlines from the last 2 months, including the FDA approval of Ebola vaccine Ervebo,…
New research suggests that sepsis may be associated with one in five deaths, double the previous estimate, but overall trends suggest incidence and mortality may be decreasing.
A novel study conducted by researchers at Harvard Medical School (MA, USA) has identified how the maternal gut microbiome could protect their newborn children from E. coli infection.
Administering the BCG vaccine intravenously, as opposed to intradermally, could improve the efficacy of the immunization according to new research in macaque models.